« Safety of Estrogen-Based Feminizing Gender-Affirming Hormone Therapy:  A Practical Endocrine Approach to Risk Stratification and Monitoring ». Canadian Diabetes & Endocrinology Today, vol. 4, nᵒ 1, mai 2026, p. 10–16, https://doi.org/10.58931/cdet.2026.4150.